Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Generic
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ZTS | Zoetis, Inc. | -0.14% | 223.02 | 1.9% | $324.03m | |
| TEVA | Teva Pharmaceutical Industries Ltd. | 2.42% | 8.25 | 2.0% | $77.34m | |
| RDY | Dr. Reddy's Laboratories Ltd. | -1.60% | 59.55 | 2.0% | $7.30m | |
| TXMD | TherapeuticsMD, Inc. | -17.98% | 0.38 | 14.2% | $2.47m | |
| JAGX | Jaguar Health, Inc. | -0.85% | 1.17 | 2.6% | $1.59m | |
| TARO | Taro Pharmaceutical Industries Ltd. | -3.08% | 52.21 | 6.6% | $0.83m | |
| COCP | Cocrystal Pharma, Inc. | -2.10% | 0.70 | 0.0% | $0.68m | |
| ABEO | Abeona Therapeutics, Inc. | 2.61% | 0.59 | 3.7% | $0.58m | |
| LFVN | LifeVantage Corp. | 4.55% | 6.43 | 3.6% | $0.36m | |
| CPHI | China Pharma Holdings, Inc. | 2.11% | 0.48 | 0.1% | $0.20m |
Company Profile
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.